Australian Clinical Labs Ltd (ACL) - Total Liabilities

Latest as of December 2025: AU$411.46 Million AUD ≈ $291.14 Million USD

Based on the latest financial reports, Australian Clinical Labs Ltd (ACL) has total liabilities worth AU$411.46 Million AUD (≈ $291.14 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore ACL net assets growth trend to track the company's year-over-year net asset growth rate.

Australian Clinical Labs Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Australian Clinical Labs Ltd's total liabilities have evolved over time, based on quarterly financial data. See Australian Clinical Labs Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Australian Clinical Labs Ltd Competitors by Total Liabilities

The table below lists competitors of Australian Clinical Labs Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Onity Group Inc. NYSE:ONIT	USA	$17.11 Billion
Nh Investment And Securities 1p KO:005945	Korea	₩89.11 Trillion
Propel Funeral Partners Ltd AU:PFP	Australia	AU$305.83 Million
Shanghai No1 Pharmacy Co Ltd SHG:600833	China	CN¥799.41 Million
D. Boral Acquisition I Corp. Class A Ordinary Shares NASDAQ:DBCA	USA	$57.20K
Aeris Resources Ltd AU:AIS	Australia	AU$257.43 Million
STIF Société anonyme PA:ALSTI	France	€24.97 Million
Carindale Property Trust AU:CDP	Australia	AU$232.30 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Australian Clinical Labs Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ACL market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.59	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.11	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.73	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.73	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Australian Clinical Labs Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Australian Clinical Labs Ltd (2016–2025)

The table below shows the annual total liabilities of Australian Clinical Labs Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$402.86 Million ≈ $285.05 Million	0.00%
2024-12-31	AU$402.86 Million ≈ $285.05 Million	-2.99%
2024-06-30	AU$415.30 Million ≈ $293.85 Million	0.00%
2023-12-31	AU$415.30 Million ≈ $293.85 Million	+2.23%
2023-06-30	AU$406.24 Million ≈ $287.44 Million	0.00%
2022-12-31	AU$406.24 Million ≈ $287.44 Million	+2.72%
2022-06-30	AU$395.49 Million ≈ $279.83 Million	0.00%
2021-12-31	AU$395.49 Million ≈ $279.83 Million	+0.69%
2021-06-30	AU$392.79 Million ≈ $277.92 Million	0.00%
2020-12-31	AU$392.79 Million ≈ $277.92 Million	+32.22%
2020-06-30	AU$297.06 Million ≈ $210.19 Million	0.00%
2019-12-31	AU$297.06 Million ≈ $210.19 Million	+135.41%
2019-06-30	AU$126.19 Million ≈ $89.29 Million	0.00%
2018-12-31	AU$126.19 Million ≈ $89.29 Million	+11.08%
2018-06-30	AU$113.60 Million ≈ $80.38 Million	0.00%
2017-12-31	AU$113.60 Million ≈ $80.38 Million	+6.40%
2017-06-30	AU$106.77 Million ≈ $75.55 Million	0.00%
2016-12-31	AU$106.77 Million ≈ $75.55 Million	--

About Australian Clinical Labs Ltd

AU:ACL Australia Diagnostics & Research

Market Cap

$309.40 Million

AU$437.28 Million AUD

Market Cap Rank

#14491 Global

#391 in Australia

Share Price

AU$2.33

Change (1 day)

+0.00%

52-Week Range

AU$1.84 - AU$2.92

All Time High

AU$5.09